Status:
COMPLETED
Proteomic Analysis of Crohn's Disease Macrophages in Response or Not to AIEC
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Laboratoire M2Ish
Conditions:
Crohn's Disease
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Brief Summary
The M2iSH laboratory showed with two previous clinical trials that Crohn's Disease (CD) macrophages present i) a defect to control Adherent-Invasive Escherichia coli (AIEC) infection related to polymo...
Detailed Description
The macrophages characterization will be realized at a basal state and in response or not to AIEC. Investigator aimed to 1) better understand the differences between macrophages of CD patients, UC pa...
Eligibility Criteria
Inclusion
- \- Crohn's Disease or ulcerative colitis or healthy volunteers
- Age \> 18 years
- Patients benefiting from the health insurance plan
- Patients who can read and attest to understanding the information note and informed consent
Exclusion
- Pregnant or breastfeeding woman
- Under guardianship or curatorship
- Refusing the genetic part of the study
Key Trial Info
Start Date :
January 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 18 2019
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT03404557
Start Date
January 18 2018
End Date
January 18 2019
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003